As we hit the mid-point of January 2018, we look at the top-performing articles on Morningstar.com.au.

Investors were particularly interested in our analysts’ views on mining and healthcare stocks, how Australian banks are expected to perform this year, our credit market outlook and other company and sector analysis.

Large-cap stocks to watch

While Australian companies in the mining and materials sectors were among the best performers in the ASX200 index at the end of 2017, that's not the full story.

 Top performing funds of 2017

The past year has seen further growth in the exchange-traded product sector, with the latest ASX data putting the sector’s total market capitalisation at more than $250 billion

5 stocks tipped for growth in 2018

These five companies spanning a range of sectors are tipped to provide good earnings growth over 2018 and beyond, according to Morningstar analysts

High-net worth investors hungry for guidance

In the year ahead, investors are particularly hungry for insights and information on equities, exchange-traded funds, managed funds and portfolio asset allocation, according to a recent survey of high-net worth investors.

How Australia's big 4 will fare this year

For all the noise building around the Federal Government's Royal Commission into Banks and Financial Services, Morningstar's senior banks analyst David Ellis reminds investors of a few home truths.

5 lessons for SMSFs from 2017, preparing for 2018

Self-managed super fund trustees have had an eventful year thanks to July's super changes and another rollercoaster ride for financial markets. Here are some lessons from the experience, and tips on how to prepare for the year ahead.

5 moat-rated dividend stocks to consider

In the ongoing low interest rate environment, income investors face challenges finding high-quality sources of dividends, but the following list may help.

Legal shift disqualifies popular SMSF tax deduction

Recent legislation changes to allowable tax deductions may have implications for SMSF trustees who hold investment property in their fund, writes Elizabeth Wang.

Investors rush to take advantage of pot stock high

The Federal Government’s decision to allow exports of medicinal cannabis products prompted an early investor rush on ASX-listed Australian medicinal cannabis producers.

Mixed bag for investors amid credit market volatility

Insights on the Australian interest rate outlook, US tax reform, and winners and losers in fixed income featured in Morningstar's Australian Credit Monthly for December 2017.

 More from Morningstar

• Unpredictability a key investment risk in 2018

• Morningstar's month in review

• Make better investment decisions with Morningstar Premium | Free 4-week trial

 

Glenn Freeman is Morningstar's senior editor.

© 2018 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written consent of Morningstar. Any general advice or 'class service' have been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/s/fsg.pdf. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782 ("ASXO"). The article is current as at date of publication.